Polyunsaturated fatty acids and epilepsy

Epilepsia

Volumn 51, Issue 8, 2010, Pages 1348-1358

  Taha, Ameer Y ^a   Burnham, W McIntyre ^a   Auvin, Stéphane ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c INSERM   (France)

Author keywords

Docosahexaenoic acid; Epilepsy; Inflammation; Ion channel; Ketogenic diet; omega 3 (n 3); Peroxisome proliferator activated receptors; Polyunsaturated fatty acids; PUFA; Seizures

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; BICUCULLINE; DOCOSAHEXAENOIC ACID; FLUROTHYL; GLUTAMIC ACID; ICOSAPENTAENOIC ACID; KAINIC ACID; LINOLEIC ACID; LINOLENIC ACID; MINERAL OIL; NAPROXEN; NIMESULIDE; OLEIC ACID; PENTETRAZOLE; PICROTOXIN; PLACEBO; ROFECOXIB; UNSATURATED FATTY ACID;

ABSENCE OF SIDE EFFECTS; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; FAT INTAKE; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; TREATMENT DURATION; ANIMAL; BIOLOGICAL MODEL; BRAIN; METABOLISM; PATHOLOGY;

ANIMALS; ANTICONVULSANTS; BRAIN; EPILEPSY; FATTY ACIDS, UNSATURATED; HUMANS; MODELS, BIOLOGICAL;

EID: 77955317064     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02654.x     Document Type: Note

References (118)

1. Aarsetoey H, Ponitz V, Grundt H, Staines H, Harris WS, Nilsen DW 2009) (n-3) Fatty acid content of red blood cells does not predict risk of future cardiovascular events following an acute coronary syndrome. J Nutr 139:507 513.
2. Aid S, Vancassel S, Poumes-Ballihaut C, Chalon S, Guesnet P, Lavialle M 2003) Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 44:1545 1551.
3. Aid S, Vancassel S, Linard A, Lavialle M, Guesnet P 2005) Dietary docosahexaenoic acid [22: 6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J Nutr 135:1008 1013.
4. Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR 2006) Omega-3 fatty acid status in attention-deficithyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 75:299 308.
5. Astorg P, Arnault N, Czernichow S, Noisette N, Galan P, Hercberg S 2004) Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 39:527 535.
6. Auvin S, Sankar R (2008). Inflammation, Epilepsy, and Anti-inflammatory Therapies. In Pellock JM, Bourgeois B, Dodson W, Nordli DR Jr., Sankar R (Eds) Pediatric epilepsy: diagnosis and therapy. 3rd ed. Demos Medical Publishing, New York, pp. 751 758.
7. Basselin M, Chang L, Seemann R, Bell JM, Rapoport SI 2005) Chronic lithium administration to rats selectively modifies 5-HT2A2C receptor-mediated brain signaling via arachidonic acid. Neuropsychopharmacology 30:461 472. (Pubitemid 40271149)
8. Basselin M, Nguyen HN, Chang L, Bell JM, Rapoport SI 2009) Acute but not chronic donepezil increases muscarinic receptor-mediated signaling via arachidonic acid in unanesthetized rats. J Alzheimers Dis 17:369 382.
9. Bazil CW 2002) New antiepileptic drugs. Neurologist 8:71 81.
10. Beadle JB, Just DE, Morgan RE, Reiners RA 1965) Composition of corn oil. J Am Oil Chem Soc 42:90 95.
11. Bernstein H, Gold H, Lang TW, Pappelbaum S, Bazika V, Corday E 1965) Sodium diphenylhydantoin in the treatment of recurrent cardiac arrhythmias. JAMA 191:695 697.
12. Billman GE, Hallaq H, Leaf A 1994) Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci USA 91:4427 4430.
13. Blondeau N, Widmann C, Lazdunski M, Heurteaux C 2002) Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 109:231 241.
14. Boland LM, Drzewiecki MM, Timoney G, Casey E 2009) Inhibitory effects of polyunsaturated fatty acids on Kv4KChIP potassium channels. Am J Physiol Cell Physiol 296:C1003 C1014.
15. Borjesson SI, Hammarstrom S, Elinder F 2008) Lipoelectric modification of ion channel voltage gating by polyunsaturated fatty acids. Biophys J 95:2242 2253.
16. Brenna JT, Salem N Jr., Sinclair AJ, Cunnane SC 2009) alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 80:85 91.
17. Bromfield E, Dworetzky B, Hurwitz S, Eluri Z, Lane L, Replansky S, Mostofsky D 2008) A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 12:187 190.
18. Burdge GC, Calder PC 2005) Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45:581 597.
19. Chan DC, Watts GF, Nguyen MN, Barrett PH 2006) Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am J Clin Nutr 84:37 43.
20. Chen CT, Liu Z, Ouellet M, Calon F, Bazinet RP 2009) Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukot Essent Fatty Acids 80:157 163.
21. Conn RD 1965) Diphenylhydantoin sodium in cardiac arrhythmias. N Engl J Med 272:277 282.
22. Crawford MA, Bazinet RP, Sinclair AJ 2009) Fat intake and CNS functioning: ageing and disease. Ann Nutr Metab 55:202 228.
23. Cunnane SC, Musa K, Ryan MA, Whiting S, Fraser DD 2002) Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins Leukot Essent Fatty Acids 67:131 135.
24. Dahlin M, Hjelte L, Nilsson S, Amark P 2007) Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res 73:199 207.
25. Davison VL, Dutton HJ 1967) Microreactor for methanolysis of triglycerides before gas-liquid chromatography. J Lipid Res 8:147 149.
26. DeGiorgio CM, Miller P, Meymandi S, Gornbein JA 2008) n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, explaratory study. Epilepsy Behav 13:681 684.
27. Demar JC Jr., Ma K, Chang L, Bell JM, Rapoport SI 2005) alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J Neurochem 94:1063 1076.
28. Denomme J, Stark KD, Holub BJ 2005) Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations. J Nutr 135:206 211.
29. Dhir A, Naidu PS, Kulkarni SK 2006a) Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action. Prog Neuropsychopharmacol Biol Psychiatry 30:1478 1485.
30. Dhir A, Naidu PS, Kulkarni SK 2006b) Effect of cyclooxygenase-2 (COX-2) inhibitors in various animal models (bicuculline, picrotoxin, maximal electroshock-induced convulsions) of epilepsy with possible mechanism of action. Indian J Exp Biol 44:286 291.
31. Dimitrova-Sumkovska J, Dosić-Markovska B, Zafirova-Roganovic D, Anastasovska V 2006) Effects of different dietary fatty acid supplements upon lipoprotein metabolism and lipid peroxides production in hyperlipidemic rats. Prilozi 27:67 86.
32. Farias SE, Basselin M, Chang L, Heidenreich KA, Rapoport SI, Murphy RC 2008) Formation of eicosanoids, E2D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J Lipid Res 49:1990 2000.
33. Fraser DD, Whiting S, Andrew RD, Macdonald EA, Musa-Veloso K, Cunnane SC 2003) Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 60:1026 1029.
34. Fratesi JA, Hogg RC, Young-Newton GS, Patterson AC, Charkhzarin P, Block TK, Sharratt MT, Stark KD 2009) Direct quantitation of omega-3 fatty acid intake of Canadian residents of a long-term care facility. Appl Physiol Nutr Metab 34:1 9.
35. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J 2006) Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 63:1402 1408.
36. Fruchart JC, Staels B, Duriez P 2001) PPARS, metabolic disease and atherosclerosis. Pharmacol Res 44:345 352.
37. Gao F, Kiesewetter D, Chang L, Ma K, Bell JM, Rapoport SI, Igarashi M 2009) Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats. J Lipid Res 50:749 758.
38. Gilby KL, Jans J, McIntyre DC 2009) Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale. Neuroscience 163:750 758.
39. Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC, Whelan J 2009) Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 139:804S 819S.
40. Hatanaka E, Levada-Pires AC, Pithon-Curi TC, Curi R 2006) Systematic study on ROS production induced by oleic, linoleic, and gamma-linolenic acids in human and rat neutrophils. Free Radic Biol Med 41:1124 1132.
41. Healy DA, Wallace FA, Miles EA, Calder PC, Newsholm P 2000) Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 35:763 768.
42. Hock CE, Beck LD, Bodine RC, Reibel DK 1990) Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion. Am J Physiol 259:H1518 H1526.
43. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN 2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells autacoids in anti-inflammation. J Biol Chem 278:14677 14687.
44. Honore E, Barhanin J, Attali B, Lesage F, Lazdunski M 1994) External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids. Proc Natl Acad Sci USA 91:1937 1941.
45. Hostetler HA, Kier AB, Schroeder F 2006) Very-long-chain and branched-chain fatty acyl-CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha). Biochemistry 45:7669 7681.
46. Igarashi M, Demar JC Jr., Ma K, Chang L, Bell JM, Rapoport SI 2007) Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J Lipid Res 48:1150 1158. (Pubitemid 46708682)
47. Kang JX, Leaf A 1994) Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 91:9886 9890.
48. Kang JX, Xiao YF, Leaf A 1995) Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA 92:3997 4001.
49. Kang JX, Leaf A 1996a) Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins. Proc Natl Acad Sci USA 93:3542 3546.
50. Kang JX, Leaf A 1996b) The cardiac antiarrhythmic effects of polyunsaturated fatty acid. Lipids 31 (suppl S41 S44.
51. Kersten S, Wahli W 2000) Peroxisome proliferator activated receptor agonists. EXS 89:141 151.
52. Kim dY, Rho JM 2008) The ketogenic diet and epilepsy. Curr Opin Clin Nutr Metab Care 11:113 120.
53. Kitajka K, Sinclair AJ, Weisinger RS, Weisinger HS, Mathai M, Jayasooriya AP, Halver JE, Puskas LG 2004) Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci USA 101:10931 10936.
54. Kodas E, Galineau L, Bodard S, Vancassel S, Guilloteau D, Besnard JC, Chalon S 2004) Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J Neurochem 89:695 702.
55. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M 2000) Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19:1784 1793.
56. Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, Salem N Jr., Frautschy SA, Cole GM 2005) A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25:3032 3040.
57. Lin Q, Ruuska SE, Shaw NS, Dong D, Noy N 1999) Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 38:185 190.
58. Lucas M, Asselin G, Plourde M, Cunnane SC, Dewailly E, Dodin S 2010) n-3 Fatty acid intake from marine food products among Quebecers: comparison to worldwide recommendations. Public Health Nutr 13:63 70.
59. Lund EK, Harvey LJ, Ladha S, Clark DC, Johnson IT 1999) Effects of dietary fish oil supplementation on the phospholipid composition and fluidity of cell membranes from human volunteers. Ann Nutr Metab 43:290 300.
60. Maurois P, Rocchi S, Pages N, Bac P, Stables JP, Gressens P, Vamecq J 2007) The PPARgamma agonist FMOC-l-leucine protects both mature and immature brain. Biomed Pharmacother 62:259 263.
61. McKenney JM, Sica D 2007) Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia. Am J Health Syst Pharm 64:595 605. (Pubitemid 46481860)
62. McLennan PL, Abeywardena MY, Charnock JS 1985) Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol 63:1411 1417.
63. Metherel AH, Taha AY, Izadi H, Stark KD 2009) The application of ultrasound energy to increase lipid extraction throughput of solid matrix samples (flaxseed). Prostaglandins Leukot Essent Fatty Acids 81:417 423.
64. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB 2005) Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112:1945 1952.
65. Mozaffarian D, Rimm EB 2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296:1885 1899.
66. Nylen K, Likhodii S, Burnham WM 2009) The ketogenic diet: proposed mechanisms of action. Neurotherapeutics 6:402 405.
67. Obajimi O, Black KD, Glen I, Ross BM 2007) Antioxidant modulation of oxidant-stimulated uptake and release of arachidonic acid in eicosapentaenoic acid-supplemented human lymphoma U937 cells. Prostaglandins Leukot Essent Fatty Acids 76:65 71.
68. Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S, LaFerla F, Bazinet RP, Calon F 2009) Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem Int 55:476 482.
69. Petit-Jacques J, Hartzell HC 1996) Effect of arachidonic acid on the L-type calcium current in frog cardiac myocytes. J Physiol 493 (Pt 1):67 81.
70. Poling JS, Vicini S, Rogawski MA, Salem N Jr. 1996) Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc. Neuropharmacology 35:969 982.
71. Porta N, Bourgois B, Galabert C, Lecointe C, Cappy P, Bordet R, Vallee L, Auvin S 2009a) Anticonvulsant effects of linolenic acid are unrelated to brain phospholipid cell membrane compositions. Epilepsia 50:65 71.
72. Porta N, Vallee L, Boutry E, Fontaine M, Dessein AF, Joriot S, Cuisset JM, Cuvellier JC, Auvin S 2009b) Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure 18:359 364.
73. Porta N, Vallee L, Lecointe C, Bouchaert E, Staels B, Bordet R, Auvin S 2009c) Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties. Epilepsia 50:943 948.
74. Rabinovitz S, Mostofsky DI, Yehuda S 2004) Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology 29, 113 124.
75. Rao JS, Ertley RN, Demar JC Jr., Rapoport SI, Bazinet RP, Lee HJ 2007) Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry 12:151 157.
76. Rapoport SI 2003) In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism. J Pediatr 143:S26 S34.
77. Rees D, Miles EA, Banerjee T, Wells SJ, Roynette CE, Wahle KW, Calder PC 2006) Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: a comparison of young and older men. Am J Clin Nutr 83:331 342.
78. Richard D, Kefi K, Barbe U, Bausero P, Visioli F 2008) Polyunsaturated fatty acids as antioxidants. Pharmacol Res 57:451 455.
79. Robinson PJ, Noronha J, DeGeorge JJ, Freed LM, Nariai T, Rapoport SI 1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev 17:187 214.
80. Sampath H, Ntambi JM 2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr 25:317 340.
81. Sarkadi-Nagy E, Huang MC, Diau GY, Kirwan R, Chueh CA, Tschanz C, Brenna JT 2003) Long chain polyunsaturate supplementation does not induce excess lipid peroxidation of piglet tissues. Eur J Nutr 42:293 296.
82. Sathe SK, Seeram NP, Kshirsagar HH, Heber D, Lapsley KA 2008) Fatty acid composition of California grown almonds. J Food Sci 73:C607 C614.
83. Schlanger S, Shinitzky M, Yam D 2002) Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43:103 104.
84. Schmidt EB, Skou HA, Christensen JH, Dyerberg J 2000) N-3 fatty acids from fish and coronary artery disease: implications for public health. Public Health Nutr 3:91 98.
85. Shafiq N, Malhotra S, Pandhi P 2003) Anticonvulsant action of celecoxib (alone and in combination with sub-threshold dose of phenytoin) in electroshock induced convulsion. Methods Find Exp Clin Pharmacol 25:87 90.
86. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH 1995) Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274:1363 1367.
87. Smith SA 2002) Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism. Biochem Soc Trans 30:1086 1090.
88. Stahl LA, Begg DP, Weisinger RS, Sinclair AJ 2008) The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs 9:57 64.
89. Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB 1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56:407 412.
90. Taha AY, Ryan MA, Cunnane SC 2005) Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism 54:1127 1132.
91. Taha AY, Baghiu BM, Lui R, Nylen K, Ma DW, Burnham WM 2006a) Lack of benefit of linoleic and alpha-linolenic polyunsaturated fatty acids on seizure latency, duration, severity or incidence in rats. Epilepsy Res 71:40 46.
92. Taha AY, Ryan MA, Cunnane SC 2006b) Markedly raised intake of saturated and monounsaturated fatty acids in rats on a high-fat ketogenic diet does not inhibit carbon recycling of 13C-alpha-linolenate. Lipids 41:933 935.
93. Taha AY, Huot PS, Reza-Lopez S, Prayitno NR, Kang JX, Burnham WM, Ma DW 2008) Seizure resistance in fat-1 transgenic mice endogenously synthesizing high levels of omega-3 polyunsaturated fatty acids. J Neurochem 105:380 388.
94. Taha AY, Filo E, Ma DW, McIntyre BW 2009a) Dose-dependent anticonvulsant effects of linoleic and alpha-linolenic polyunsaturated fatty acids on pentylenetetrazol induced seizures in rats. Epilepsia 50:72 82.
95. Taha AY, Alizadeh S, Zeng QH, Filo E, McPherson JP, Burnham WM 2009b) Assessing the metabolic and toxic effects of anticonvulsant doses of polyunsaturated fatty acids on the liver in rats. J Toxicol Environ Health A 72:1191 1200.
96. Taha AY, Jeffrey MA, Taha NM, Bala S, Burnham WM 2010) Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats. Epilepsy Behav 17:336 343.
97. Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G 2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372:1223 1230.
98. Tu B, Bazan NG 2003) Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol 179:167.
99. Umhau JC, Zhou W, Carson RE, Rapoport SI, Polozova A, Demar J, Hussein N, Bhattacharjee AK, Ma K, Esposito G, Majchrzak S, Herscovitch P, Eckelman WC, Kurdziel KA, Salem N Jr. 2009) Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 50:1259 1268.
100. Vancassel S, Leman S, Hanonick L, Denis S, Roger J, Nollet M, Bodard S, Kousignian I, Belzung C, Chalon S 2008) n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. J Lipid Res 49:340 348.
101. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG 1999) Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19:5054 5065.
102. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De LA, De Simoni MG, Sperk G, ndell-Jonsson S, Lundkvist J, Iverfeldt K, Bartfai T 2000) Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci USA 97:11534 11539.
103. Vezzani A, Granata T 2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46:1724 1743.
104. Voskuyl RA, Vreugdenhil M, Kang JX, Leaf A 1998) Anticonvulsant effect of polyunsaturated fatty acids in rats, using the cortical stimulation model. Eur J Pharmacol 341:145 152.
105. Vreugdenhil M, Bruehl C, Voskuyl RA, Kang JX, Leaf A, Wadman WJ 1996) Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 93:12559 12563.
106. Willis S, Samala R, Rosenberger TA, Borges K 2009) Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models. Epilepsia 50:138 142.
107. Xiao YF, Kang JX, Morgan JP, Leaf A 1995) Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 92:11000 11004.
108. + currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 94:4182 4187.
109. Xiao Y, Li X 1999) Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res 846:112 121.
110. Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, Inaba Y, Tanabe N, Tamakoshi A 2008) Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 52:988 996.
111. Yehuda S, Carasso RL, Mostofsky DI 1994) Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 254:193 198.
112. Yehuda S, Brandys Y, Blumenfeld A, Mostofsky DI 1996) Essential fatty acid preparation reduces cholesterol and fatty acids in rat cortex. Int J Neurosci 86:249 256.
113. Young C, Gean PW, Chiou LC, Shen YZ 2000) Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 37:90 94.
114. Yuen AW, Sander JW, Fluegel D, Patsalos PN, Bell GS, Johnson T, Koepp MJ 2005) Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 7:253 258.
115. Zeldin DC 2001) Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276:36059 36062.
116. Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH 2009) Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med 41:301 310.
117. Zimmer L, Delpal S, Guilloteau D, Aioun J, Durand G, Chalon S 2000) Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 284:25 28.
118. Zimmer L, Vancassel S, Cantagrel S, Breton P, Delamanche S, Guilloteau D, Durand G, Chalon S 2002) The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr 75:662 667.